Epicardium formation as a sensor in toxicology

Journal of Developmental Biology

Volumn 1, Issue 2, 2013, Pages 112-125

  Hofsteen, Peter ^a   Plavicki, Jessica ^a   Peterson, Richard E ^a   Heideman, Warren ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

AHR; Epicardium; Heart regeneration; Proepicardium; TCDD

Indexed keywords

EID: 84929333496     PISSN: None     EISSN: 22213759     Source Type: Journal    
DOI: 10.3390/jdb1020112     Document Type: Review

References (83)

1. Lloyd-Jones, D.; Adams, R.J.; Brown, T.M.; Carnethon, M.; Dai, S.; De Simone, G.; Ferguson, T.B.; Ford, E.; Furie, K.; Gillespie, C.; Go, A.; Greenlund, K.; Haase, N.; Hailpern, S.; Ho, P.M.; Howard, V.; Kissela, B.; Kittner, S.; Lackland, D.; Lisabeth, L.; Marelli, A.; McDermott, M.M.; Meigs, J.; Mozaffarian, D.; Mussolino, M.; Nichol, G.; Roger, V.L.; Rosamond, W.; Sacco, R.; Sorlie, P.; Stafford, R.; Thom, T.; Wasserthiel-Smoller, S.; Wong, N.D.; Wylie-Rosett, J. Executive summary: Heart disease and stroke statistics--2010 update: A report from the American Heart Association. Circulation 2010, 121, 948-954.
2. Tsibiribi, P.; Bui-Xuan, C.; Bui-Xuan, B.; Lombard-Bohas, C.; Duperret, S.; Belkhiria, M.; Tabib, A.; Maujean, G.; Descotes, J.; Timour, Q. Cardiac lesions induced by 5-fluorouracil in the rabbit. Hum. Exp. Toxicol. 2006, 25, 305-309.
3. Yeh, E.T.; Tong, A.T.; Lenihan, D.J.; Yusuf, S.W.; Swafford, J.; Champion, C.; Durand, J.B.; Gibbs, H.; Zafarmand, A.A.; Ewer, M.S. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 2004, 109, 3122-3131.
4. Guldner, N.W.; Bastian, F.; Weigel, G.; Zimmermann, H.; Maleika, M.; Scharfschwerdt, M.; Rohde, D.; Sievers, H.H. Nanocoating with titanium reduces iC3b- and granulocyte-activating immune response against glutaraldehyde-fixed bovine pericardium: A new technique to improve biologic heart valve prosthesis durability-J. Thorac. Cardiovasc. Surg. 2012, 143, 1152-1159.
5. Guldner, N.W.; Jasmund, I.; Zimmermann, H.; Heinlein, M.; Girndt, B.; Meier, V.; Fluss, F.; Rohde, D.; Gebert, A.; Sievers, H.H. Detoxification and endothelialization of glutaraldehydefixed bovine pericardium with titanium coating: A new technology for cardiovascular tissue engineering. Circulation 2009, 119, 1653-1660.
6. Neethling, W.M.; Glancy, R.; Hodge, A.J. Mitigation of calcification and cytotoxicity of a glutaraldehyde-preserved bovine pericardial matrix: Improved biocompatibility after extended implantation in the subcutaneous rat model. J. Heart Valve Dis. 2010, 19, 778-785.
7. Abejie, B.A.; Chung, E.H.; Nesto, R.W.; Kales, S.N. Grand rounds: asbestos-related pericarditis in a boiler operator. Environ. Health Perspect. 2008, 116, 86-89.
8. Imanishi, S.; Arita, M. Electrophysiologic properties differ in the ventricular endocardium and epicardium of the Japanese monkey. J. Electrocardiol. 1987, 20, 185-192.
9. Staszewska-Woolley, J.; Woolley, G. Participation of the kallikrein-kinin-receptor system in reflexes arising from neural afferents in the dog epicardium. J. Physiol. 1989, 419, 33-44.
10. Lukas, A.; Antzelevitch, C. Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia. Role of the transient outward current. Circulation 1993, 88, 2903-2915.
11. Han, W.; Barr, S.C.; Pacioretty, L.M.; Gilmour, R.F., Jr. Restoration of the transient outward potassium current by noradrenaline in chagasic canine epicardium. J. Physiol. 1997, 500, 75-83.
12. Pagan-Carlo, L.A.; Garcia, L.A.; Hutchison, J.L.; Buettner, G.R.; Kerber, R.E. Captopril lowers coronary venous free radical concentration after direct current cardiac shocks. Chest 1999, 116, 484-487.
13. Kharin, S.N.; Krandycheva, V.V.; Strelkova, M.V.; Tsvetkova, A.S.; Shmakov, D.N. Doxorubicin-induced changes of ventricular repolarization heterogeneity: Results of a chronic rat study. Cardiovasc. Toxicol. 2012, 12, 312-317.
14. Allison, P.; Huang, T.; Broka, D.; Parker, P.; Barnett, J.V.; Camenisch, T.D. Disruption of canonical TGFbeta-signaling in murine coronary progenitor cells by low level arsenic. Toxicol. Appl. Pharmacol. 2013, doi: 10.1016/j.taap.2013.04.035.
15. Olivey, H.E.; Mundell, N.A.; Austin, A.F.; Barnett, J.V. Transforming growth factor-beta stimulates epithelial-mesenchymal transformation in the proepicardium. Dev. Dyn. 2006, 235, 50-59.
16. Sabir, I.N.; Li, L.M.; Jones, V.J.; Goddard, C.A.; Grace, A.A.; Huang, C.L. Criteria for arrhythmogenicity in genetically-modified Langendorff-perfused murine hearts modelling the congenital long QT syndrome type 3 and the Brugada syndrome. Pflugers Arch. 2008, 455, 637-651.
17. Tu, W.; Niu, L.; Liu, W.; Xu, C. Embryonic exposure to butachlor in zebrafish (Danio rerio): endocrine disruption, developmental toxicity and immunotoxicity. Ecotoxicol. Environ. Saf. 2013, 89, 189-195.
18. Li, X.; Ma, Y.; Li, D.; Gao, X.; Li, P.; Bai, N.; Luo, M.; Tan, X.; Lu, C.; Ma, X. Arsenic impairs embryo development via down-regulating Dvr1 expression in zebrafish. Toxicol. Lett. 2012, 212, 161-168.
19. Incardona, J.P.; Linbo, T.L.; Scholz, N.L. Cardiac toxicity of 5-ring polycyclic aromatic hydrocarbons is differentially dependent on the aryl hydrocarbon receptor 2 isoform during zebrafish development. Toxicol. Appl. Pharmacol. 2011, 257, 242-249.
20. Valesio, E.G.; Zhang, H.; Zhang, C. Exposure to the JNK inhibitor SP600125 (anthrapyrazolone) during early zebrafish development results in morphological defects. J. Appl. Toxicol. 2013, 33, 32-40.
21. Lin, C.C.; Hui, M.N.; Cheng, S.H. Toxicity and cardiac effects of carbaryl in early developing zebrafish (Danio rerio) embryos. Toxicol. Appl. Pharmacol. 2007, 222, 159-168.
22. Reimers, M.J.; Flockton, A.R.; Tanguay, R.L. Ethanol- and acetaldehyde-mediated developmental toxicity in zebrafish. Neurotoxicol. Teratol. 2004, 26, 769-781.
23. Lefebvre, K.A.; Trainer, V.L.; Scholz, N.L. Morphological abnormalities and sensorimotor deficits in larval fish exposed to dissolved saxitoxin. Aquat. Toxicol. (Amsterdam, Netherlands) 2004, 66, 159-170.
24. Hu, N.; Sedmera, D.; Yost, H.J.; Clark, E.B. Structure and function of the developing zebrafish heart. Anat. Rec. 2000, 260, 148-157.
25. Lee, R.K.; Stainier, D.Y.; Weinstein, B.M.; Fishman, M.C. Cardiovascular development in the zebrafish. II. Endocardial progenitors are sequestered within the heart field. Development 1994, 120, 3361-3366.
26. Stainier, D.Y. Zebrafish genetics and vertebrate heart formation. Nat. Rev. Genet. 2001, 2, 39-48.
27. Bakkers, J. Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovasc. Res. 2011, 91, 279-288.
28. Serluca, F.C. Development of the proepicardial organ in the zebrafish. Dev. Biol. 2008, 315, 18-27.
29. Manner, J.; Perez-Pomares, J.M.; Macias, D.; Munoz-Chapuli, R. The origin, formation and developmental significance of the epicardium: a review. Cells Tissues Organs 2001, 169, 89-103.
30. Manner, J.; Schlueter, J.; Brand, T. Experimental analyses of the function of the proepicardium using a new microsurgical procedure to induce loss-of-proepicardial-function in chick embryos. Dev. Dyn. 2005, 233, 1454-1463.
31. Lie-Venema, H.; van den Akker, N.M.; Bax, N.A.; Winter, E.M.; Maas, S.; Kekarainen, T.; Hoeben, R.C.; deRuiter, M.C.; Poelmann, R.E.; Gittenberger-de Groot, A.C. Origin, fate, and function of epicardium-derived cells (EPDCs) in normal and abnormal cardiac development. Sci. World J. 2007, 7, 1777-1798.
32. Gittenberger-de Groot, A.C.; Winter, E.M.; Bartelings, M.M.; Jose Goumans, M.; Deruiter, M.C.; Poelmann, R.E. The arterial and cardiac epicardium in development, disease and repair. Differentiation 2012, 84, 41-53.
33. Riley, P.R. An epicardial floor plan for building and rebuilding the mammalian heart. Curr. Top. Dev. Biol. 2012, 100, 233-251.
34. Smart, N.; Riley, P.R. The epicardium as a candidate for heart regeneration. Future Cardiol. 2012, 8, 53-69.
35. Smart, N.; Dube, K.N.; Riley, P.R. Epicardial progenitor cells in cardiac regeneration and neovascularisation. Vascul. Pharmacol. 2012.
36. Hill, A.J.; Teraoka, H.; Heideman, W.; Peterson, R.E. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol. Sci. 2005, 86, 6-19.
37. Wells, P.; Pinder, A. The respiratory development of Atlantic salmon. II. Partitioning of oxygen uptake among gills, yolk sac and body surfaces. J. Exp. Biol. 1996, 199, 2737-2744.
38. Kopp, R.; Schwerte, T.; Pelster, B. Cardiac performance in the zebrafish breakdance mutant. J. Exp. Biol. 2005, 208, 2123-2134.
39. Stainier, D.Y.; Fouquet, B.; Chen, J.N.; Warren, K.S.; Weinstein, B.M.; Meiler, S.E.; Mohideen, M.A.; Neuhauss, S.C.; Solnica-Krezel, L.; Schier, A.F.; Zwartkruis, F.; Stemple, D.L.; Malicki, J.; Driever, W.; Fishman, M.C. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development (Cambridge, England) 1996, 123, 285-292.
40. Thackaberry, E.A.; Nunez, B.A.; Ivnitski-Steele, I.D.; Friggins, M.; Walker, M.K. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on murine heart development: Alteration in fetal and postnatal cardiac growth, and postnatal cardiac chronotropy. Toxicol. Sci. 2005, 88, 242-249.
41. Cheung, M.O.; Gilbert, E.F.; Peterson, R.E. Cardiovascular teratogenicity of 2, 3, 7, 8- tetrachlorodibenzo-p-dioxin in the chick embryo. Toxicol. Appl. Pharmacol. 1981, 61, 197-204.
42. Peterson, R.E.; Theobald, H.M.; Kimmel, G.L. Developmental and reproductive toxicity of dioxins and related compounds: cross-species comparisons. Crit. Rev. Toxicol. 1993, 23, 283-335.
43. Carney, S.A.; Chen, J.; Burns, C.G.; Xiong, K.M.; Peterson, R.E.; Heideman, W. Aryl hydrocarbon receptor activation produces heart-specific transcriptional and toxic responses in developing zebrafish. Mol. Pharmacol. 2006, 70, 549-561.
44. King-Heiden, T.C.; Mehta, V.; Xiong, K.M.; Lanham, K.A.; Antkiewicz, D.S.; Ganser, A.; Heideman, W.; Peterson, R.E. Reproductive and developmental toxicity of dioxin in fish. Mol. Cell. Endocrinol. 2012, 354, 121-138.
45. Kopf, P.G.; Walker, M.K. Overview of developmental heart defects by dioxins, PCBs, and pesticides. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2009, 27, 276-285.
46. Cronk, C.E.; Pelech, A.N.; Malloy, M.E.; McCarver, D.G. Excess birth prevalence of Hypoplastic Left Heart syndrome in eastern Wisconsin for birth cohorts 1997-1999. Birth Defects Res. 2004, 70, 114-120.
47. Kuehl, K.S.; Loffredo, C.A. A cluster of hypoplastic left heart malformation in Baltimore, Maryland. Pediatric Cardiol. 2006, 27, 25-31.
48. Flesch-Janys, D.; Berger, J.; Gurn, P.; Manz, A.; Nagel, S.; Waltsgott, H.; Dwyer, J.H. Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany. Am. J. Epidemiol. 1995, 142, 1165-1175.
49. Bertazzi, P.A.; Bernucci, I.; Brambilla, G.; Consonni, D.; Pesatori, A.C. The Seveso studies on early and long-term effects of dioxin exposure: a review. Environ. Health Perspect. 1998, 106 (Suppl. 2), 625-633.
50. Lanham, K.A.; Peterson, R.E.; Heideman, W. Sensitivity to dioxin decreases as zebrafish mature. Toxicol. Sci. 2012, 127, 360-370.
51. Henry, T.R.; Spitsbergen, J.M.; Hornung, M.W.; Abnet, C.C.; Peterson, R.E. Early life stage toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in zebrafish (Danio rerio). Toxicol. Appl. Pharmacol. 1997, 142, 56-68.
52. Dong, W.; Teraoka, H.; Tsujimoto, Y.; Stegeman, J.J.; Hiraga, T. Role of aryl hydrocarbon receptor in mesencephalic circulation failure and apoptosis in zebrafish embryos exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 2004, 77, 109-116.
53. Antkiewicz, D.S.; Burns, C.G.; Carney, S.A.; Peterson, R.E.; Heideman, W. Heart malformation is an early response to TCDD in embryonic zebrafish. Toxicol. Sci. 2005, 84, 368-377.
54. Belair, C.D.; Peterson, R.E.; Heideman, W. Disruption of erythropoiesis by dioxin in the zebrafish. Dev. Dyn. 2001, 222, 581-594.
55. Mehta, V.; Peterson, R.E.; Heideman, W. 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure Prevents Cardiac Valve Formation in Developing Zebrafish. Toxicol. Sci. 2008, 104, 303-311.
56. Plavicki, J.; Hofsteen, P.; Peterson, R.E.; Heideman, W. Dioxin inhibits zebrafish epicardium and proepicardium development. Toxicol. Sci. 2013, 131, 558-567.
57. Garrity, D.M.; Childs, S.; Fishman, M.C. The heartstrings mutation in zebrafish causes heart/fin Tbx5 deficiency syndrome. Development 2002, 129, 4635-4645.
58. Liu, J.; Stainier, D.Y. Tbx5 and Bmp signaling are essential for proepicardium specification in zebrafish. Circulation Res. 2010, 106, 1818-1828.
59. Hofsteen, P.; Mehta, V.; Kim, M.S.; Peterson, R.E.; Heideman, W. TCDD inhibits heart regeneration in adult zebrafish. Toxicol. Sci. 2013, 132, 211-221.
60. Thackaberry, E.A.; Jiang, Z.; Johnson, C.D.; Ramos, K.S.; Walker, M.K. Toxicogenomic profile of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the murine fetal heart: Modulation of cell cycle and extracellular matrix genes. Toxicol. Sci. 2005, 88, 231-241.
61. Jenkins, S.J.; Hutson, D.R.; Kubalak, S.W. Analysis of the proepicardium-epicardium transition during the malformation of the RXRalpha-/- epicardium. Dev. Dyn. 2005, 233, 1091-1101.
62. Acharya, A.; Baek, S.T.; Huang, G.; Eskiocak, B.; Goetsch, S.; Sung, C.Y.; Banfi, S.; Sauer, M.F.; Olsen, G.S.; Duffield, J.S.; Olson, E.N.; Tallquist, M.D. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 2012, 139, 2139-2149.
63. Smith, C.L.; Baek, S.T.; Sung, C.Y.; Tallquist, M.D. Epicardial-derived cell epithelial-tomesenchymal transition and fate specification require PDGF receptor signaling. Circulation Res. 2011, 108, e15-e26.
64. Muller, P.S.; Schulz, R.; Maretto, S.; Costello, I.; Srinivas, S.; Bikoff, E.; Robertson, E. The fibronectin leucine-rich repeat transmembrane protein Flrt2 is required in the epicardium to promote heart morphogenesis. Development 2011, 138, 1297-1308.
65. Muto, A.; Calof, A.L.; Lander, A.D.; Schilling, T.F. Multifactorial origins of heart and gut defects in nipbl-deficient zebrafish, a model of Cornelia de Lange Syndrome. PLoS Biol. 2011, 9, e1001181.
66. Mitchell, I.C.; Brown, T.S.; Terada, L.S.; Amatruda, J.F.; Nwariaku, F.E. Effect of vascular cadherin knockdown on zebrafish vasculature during development. PLoS One 2010, 5, e8807.
67. Pruvot, B.; Quiroz, Y.; Voncken, A.; Jeanray, N.; Piot, A.; Martial, J.A.; Muller, M. A panel of biological tests reveals developmental effects of pharmaceutical pollutants on late stage zebrafish embryos. Reprod. Toxicol. 2012, 34, 568-583.
68. Gurvich, N.; Berman, M.G.; Wittner, B.S.; Gentleman, R.C.; Klein, P.S.; Green, J.B. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. Faseb J. 2005, 19, 1166-1168.
69. Reinecke, H.; Minami, E.; Zhu, W.Z.; Laflamme, M.A. Cardiogenic differentiation and transdifferentiation of progenitor cells. Circ. Res. 2008, 103, 1058-1071.
70. Malki, Q.; Sharma, N.D.; Afzal, A.; Ananthsubramaniam, K.; Abbas, A.; Jacobson, G.; Jafri, S. Clinical presentation, hospital length of stay, and readmission rate in patients with heart failure with preserved and decreased left ventricular systolic function. Clin. Cardiol. 2002, 25, 149-152.
71. Bolli, P.; Chaudhry, H.W. Molecular physiology of cardiac regeneration. Ann. N. Y. Acad. Sci. 2010, 1211, 113-126.
72. Smart, N.; Bollini, S.; Dube, K.N.; Vieira, J.M.; Zhou, B.; Riegler, J.; Price, A.N.; Lythgoe, M.F.; Davidson, S.; Yellon, D.; Pu, W.T.; Riley, P.R. Myocardial regeneration: expanding the repertoire of thymosin beta4 in the ischemic heart. Ann. N. Y. Acad. Sci. 2012, 1269, 92-101.
73. Poss, K.D.; Wilson, L.G.; Keating, M.T. Heart regeneration in zebrafish. Science 2002, 298, 2188-2190.
74. Kikuchi, K.; Holdway, J.E.; Werdich, A.A.; Anderson, R.M.; Fang, Y.; Egnaczyk, G.F.; Evans, T.; Macrae, C.A.; Stainier, D.Y.; Poss, K.D. Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature 2010, 464, 601-605.
75. Jopling, C.; Sleep, E.; Raya, M.; Marti, M.; Raya, A.; Belmonte, J.C. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 2010, 464, 606-609.
76. Lepilina, A.; Coon, A.N.; Kikuchi, K.; Holdway, J.E.; Roberts, R.W.; Burns, C.G.; Poss, K.D. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 2006, 127, 607-619.
77. Choi, W.Y.; Poss, K.D. Cardiac regeneration. Curr. Top. Dev. Biol. 2012, 100, 319-344.
78. Kikuchi, K.; Holdway, J.E.; Major, R.J.; Blum, N.; Dahn, R.D.; Begemann, G.; Poss, K.D. Retinoic acid production by endocardium and epicardium is an injury response essential for zebrafish heart regeneration. Dev. Cell 2011, 20, 397-404.
79. Di Meglio, F.; Castaldo, C.; Nurzynska, D.; Romano, V.; Miraglia, R.; Montagnani, S. Epicardial cells are missing from the surface of hearts with ischemic cardiomyopathy: A useful clue about the self-renewal potential of the adult human heart-Int. J. Cardiol. 2010, 145, e44-e46.
80. Milan, D.J.; Jones, I.L.; Ellinor, P.T.; MacRae, C.A. In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am. J. Physiol. Heart Circ. Physiol. 2006, 291, H269-H273.
81. Park, M.J.; Lee, K.R.; Shin, D.S.; Chun, H.S.; Kim, C.H.; Ahn, S.H.; Bae, M.A. Predicted druginduced bradycardia related cardio toxicity using a zebrafish in vivo model is highly correlated with results from in vitro tests. Toxicol. Lett. 2013, 216, 9-15.
82. Parng, C.; Seng, W.L.; Semino, C.; McGrath, P. Zebrafish: a preclinical model for drug screening. Assay Drug Dev. Technol. 2002, 1, 41-48.
83. Kikuchi, K.; Gupta, V.; Wang, J.; Holdway, J.E.; Wills, A.A.; Fang, Y.; Poss, K.D. tcf21+ epicardial cells adopt non-myocardial fates during zebrafish heart development and regeneration. Development (Cambridge, England) 2011, 138, 2895-2902.